Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02273063 · ClinicalTrials.gov registry record · NA

rTMS for PTSD Comorbid With Major Depressive Disorder

A NA study of Major Depressive Disorder and Posttraumatic Stress Disorder, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT02273063 is a NA study of Major Depressive Disorder and Posttraumatic Stress Disorder that has completed, run by Butler Hospital. The registered enrollment target is 40 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02273063, a NA study of Major Depressive Disorder and Posttraumatic Stress Disorder, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to see how well a treatment called "Repetitive Transcranial Magnetic Stimulation" works for patients who struggle with symptoms of both posttraumatic stress disorder and major depressive disorder.

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS)

Study Locations (2)

Rhode Island

  • Butler Hospital - Providence
  • Providence VA Medical Center - Providence

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-10
Est. Completion 2016-04-22
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT02273063

The ClinicalTrials.gov registry entry for NCT02273063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.

NCT02273063 reports 2 study locations spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02273063 about?

NCT02273063 is a clinical study titled "rTMS for PTSD Comorbid With Major Depressive Disorder". The purpose of this study is to see how well a treatment called "Repetitive Transcranial Magnetic Stimulation" works for patients who struggle with symptoms of both posttraumatic stress disorder and major depressive disorder.

What is the current status of trial NCT02273063?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-10. Estimated completion is 2016-04-22.

What conditions does trial NCT02273063 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Posttraumatic Stress Disorder, Transcranial Magnetic Stimulation Repetitive.

What interventions are being tested in trial NCT02273063?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT02273063?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02273063 being conducted?

This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.